Send the following on WhatsApp
Continue to Chathttps://www.marketscreener.com/quote/stock/OCERA-THERAPEUTICS-INC-13643868/news/Ocera-Initiates-Phase-2a-Study-with-Oral-OCR-002-in-Patients-with-Cirrhosis-24523581/?utm_source=whatsapp&utm_medium=social&utm_campaign=share